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        Introduction 
  Mannose 6-phosphate receptors (MPRs) carry newly synthe-
sized lysosomal enzymes from the Golgi to early endosomes 
and then return to the TGN to retrieve additional cargo (  Ghosh 
et al., 2003  ). However, MPRs cannot release their bound lig-
ands upon arrival in early endosomes because they require a 
lower pH than typical endocytic receptors for effi  cient ligand 
release (  Tong and Kornfeld, 1989  ). Thus, MPRs must pass 
through a compartment of pH  ≤  5.5 before returning to the Golgi 
to carry out their biological function. 
 In CHO cells, MPRs appear to traffi  c via so-called recycling 
endosomes before arrival in the Golgi, but these pH-neutral com-
partments also cannot support ligand release (  Lin et al., 2004  ). 
Moreover, in many cell types, the majority of MPRs reside in 
more acidic late endosomes at steady state (  Griffi  ths et al., 1988  ). 
The fi  nding that the late endosomal Rab9 GTPase is required for 
MPR recycling (  Lombardi et al., 1993  ;   Riederer et al., 1994  ; 
  Iversen et al., 2001  ;   Ganley et al., 2004  ) supports a model in which 
MPRs travel through late endosomes before arrival at the TGN. 
Thus, MPRs may travel from early endosomes to recycling endo-
somes to late endosomes en route to the Golgi complex. We focus 
on this last stage in the MPR recycling process. 
  Rab9-dependent transport from late endosomes to the 
Golgi requires the Rab9 effectors p40 (  Diaz et al., 1997  ) and 
TIP47 (  Diaz and Pfeffer, 1998  ), a protein that recognizes the 
cytoplasmic domains of the two types of MPRs and packages 
them into nascent transport vesicles (  Carroll et al., 2001  ). 
MPR re  cycling also utilizes a TGN-localized coiled-coil pro-
tein named GCC185 that is also a Rab9 effector (  Reddy et al., 
2006 ;   Derby et al., 2007  ). GCC185 is a putative transport 
vesicle tether that contains a so-called GRIP domain at its 
C terminus (  Luke et al., 2003  ). 
  SNARE proteins mediate the ultimate fusion of vesicles 
after they have docked at their corresponding target membrane 
(  Jahn and Scheller, 2006  ). To date, the identity of the SNARE 
complex that mediates vesicle fusion in MPR recycling has 
  remained unknown (  Bonifacino and Rojas, 2006  ). A separate 
transport pathway carries certain proteins such as Shiga toxin, 
cholera toxin, and ricin from early endosomes to the Golgi com-
plex (  Spooner et al., 2006  ). This pathway utilizes a SNARE 
complex containing syntaxin 6 (STX6), STX16, Vti1a, and the 
v-SNAREs VAMP3 or VAMP4 as well as the Rab6A GTPase 
(  Mallard et al., 2002  ) but not Rab9 GTPase (  Iversen et al., 2001  ; 
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  Smith et al., 2006  ). A second SNARE complex comprised of 
STX5, GS28, Ykt6, and GS15 may also be involved in early 
  endosome to Golgi transport (  Tai et al., 2004  ), but this complex 
is most likely involved in retrograde transport through the Golgi. 
In addition, Lu et al. (2004) have shown a role for Golgin-97 in 
this process. 
  Recent work has shown that STX16 is needed for MPR 
recycling to the TGN (  Saint-Pol et al., 2004  ;   Amessou et al., 
2007  ), which suggested that MPRs are transported together 
with Shiga toxin from early endosomes back to the Golgi and 
use the same STX6  –  STX16  –  Vti1a SNARE complex. In this study, 
we confi  rm a role for STX16 but show that this t-SNARE acts as 
part of a distinct STX10-containing SNARE complex to medi-
ate MPR recycling to the TGN. Although TGN46 and cholera 
toxin require STX6, MPR recycling does not: the STX10-
containing SNARE complex functions specifi  cally for MPR re-
cycling in human cells. One component of the STX10 complex 
binds to the putative tether GCC185 directly, and this interaction 
is competed by the Rab6 GTPase. This study identifies key 
molecular components that distinguish two membrane transport 
pathways to the Golgi. 
  Results 
  Two approaches were taken to identify the SNARE proteins 
  responsible for MPR transport to the Golgi. First, we tested the 
ability of antibodies to block the transport of cation-dependent 
(CD) MPR to the TGN in vitro. SNARE identifi  cation was ini-
tially hindered by the lack of cross-reactivity of anti-SNARE 
antibodies with the CHO cell components of our original in vitro 
transport assays (  Itin et al., 1997  ). To circumvent this, we re-
established our in vitro transport assay using an HEK293 human 
cell line that stably expresses a tagged version of the CD-MPR 
containing an N-terminal His tag for purifi  cation, a myc-tag 
for localization, and a consensus tyrosine sulfation site that can 
be modifi  ed by tyrosine sulfotransferase upon its arrival at the 
TGN (  Itin et al., 1997  ). 
  As shown in   Fig. 1 A  , anti-STX16 and -Vti1a antibodies 
inhibited in vitro transport in a concentration-dependent man-
ner, but anti-STX6 antibodies did not. STX6 is required for the 
transport of Shiga toxin and cholera toxin from early endosomes 
to the Golgi complex (  Mallard et al., 2002  ). Three monoclonal 
and one polyclonal anti-Rab6 antibody were tried without effect 
(Fig. S1 A, available at http://www.jcb.org/cgi/content/full/
jcb.200707136/DC1). This observation provided an important 
molecular distinction between these two transport pathways, 
which have already been shown to differ in their requirements 
  Figure 1.       Retrograde transport of MPRs to the TGN is mediated by STX10, 
STX16, Vti1a, and VAMP3.   (A) In vitro transport of CD-MPRs in reactions 
containing 100   μ  g/ml (light gray bars) or 200   μ  g/ml (dark GRAY bars) 
anti-SNARE IgG. Cytosol-dependent transport is expressed as a percent-
age of the control reaction containing the equivalent amount of nonspeciﬁ  c 
IgG. Error bars represent SD; data are from three independent experi-
ments. (B) In vitro transport of MPRs in reactions containing 200   μ  g/ml 
of the indicated IgG. (C) Coomassie-stained SDS-PAGE of recombinant 
SNAREs used in D. Each lane contains 15   μ  g of puriﬁ  ed protein except 
the lanes for STX10 and Vti1b, which contain 10   μ  g of puriﬁ  ed protein. 
(D) In vitro transport of MPRs in reactions containing 100   μ  g/ml GST alone 
(3.8   μ  M), GST-tagged versions of soluble STX5 (1.8   μ  M), STX6 (1.9   μ  M), 
STX10 (2   μ  M), STX11 (1.8   μ  M), STX16 (1.9   μ  M), Vti1a (2.3   μ  M), Vti1b 
(2.3   μ  M), VAMP3 (2.8   μ  M), VAMP7 (2.7   μ  M), VAMP8 (2.6   μ  M), or thrombin-
cleaved soluble domains of STX13 (3.5   μ  M) and VAMP4 (7.1   μ  M). 
(B and D) Error bars represent SD from at least two independent experiments 
performed in triplicate. The dashed line demarcates 100%. (E) In vitro 
transport of MPRs in reactions containing the indicated amounts of GST-
soluble SNARE protein. Values are means from at least two independent 
experiments performed in triplicate.     
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aminidase secretion can be used to monitor a block in MPR 
traffi  cking. We have shown this to be true in cells expressing a 
dominant inhibitory Rab9 protein (  Riederer et al., 1994  ) or de-
pleted of the putative tether, GCC185 (  Reddy et al., 2006  ). 
  Expression of soluble versions of STX10, STX16, and Vti1a 
but not STX6, STX13, or VAMP4 led to roughly a doubling in the 
amount of hexosaminidase secreted (  Fig. 2 A  ). Comparison of 
the levels of exogenous SNARE protein ex  pression (  Fig. 2 B  ) 
for the Rab9 GTPase (  Iversen et al., 2001  ) and the putative 
tether, Golgin-97 (  Lu et al., 2004  ;   Reddy et al., 2006  ). 
  To determine whether these SNARE antibodies inhibited 
a Rab9-dependent step, we tested whether the addition of both 
anti-Rab9 IgG and anti-STX16 IgG led to an even greater level 
of inhibition. As shown in   Fig. 1 B  , anti-STX16 and anti-Rab9 
antibodies each inhibited in vitro transport    40 – 50%.  When 
added together, no further inhibition was observed. This sug-
gests that Rab9 and STX16 antibodies are inhibiting the same 
transport process in vitro. 
  As a second independent test for SNARE involvement, we 
expressed and purifi  ed soluble forms of 12 TGN and endosome-
localized SNARE proteins (  Fig. 1 C  ) and tested their ability 
to inhibit in vitro transport reactions by presumably forming 
nonfunctional complexes with endogenous SNARE proteins. 
In agreement with the antibody inhibition data (  Fig. 1 A  ), soluble 
GST-tagged STX16 and Vti1a proteins inhibited transport 
    50  –  60% (  Fig. 1 D  ). Removal of GST by thrombin cleavage 
of GST-STX16 yielded the same level of transport inhibition 
(41   ±   0.1% MPR transport relative to control reactions). In ad-
dition, STX10 and soluble VAMP3 and 4 inhibited transport 
(  Fig. 1 D  ). In contrast, soluble STX5, 6, 11, 13, Vti1b, and VAMP7 
and 8 were without signifi  cant effect (  Fig. 1 D  ). 
  STX6 and 13 function in early endosome fusion (  McBride 
et al., 1999  ;   Mills et al., 2001  ;   Sun et al., 2003; Brandhorst et al., 
2006  ); VAMP7 and 8 are involved in early to late endosome 
  fusion (  Antonin et al., 2000a  ,  b  ;   Pryor et al., 2004  ). The inability of 
these soluble SNAREs to inhibit in vitro transport confi  rms that 
we are indeed inhibiting the late endosome to TGN transport of 
MPRs and not an interendosomal transport process. 
  Analysis of the concentration dependence of the inhibition 
observed showed that transport could be inhibited as much as 
70% with    2   μ  M STX10, STX16, and Vti1a (  Fig. 1 E  ). VAMP3 
and 4 were less potent but also showed concentration-dependent 
inhibition. When evaluated on a concentration basis (  Fig. 1 E  ), 
VAMP3 was signifi  cantly more potent than VAMP4 and is likely 
to be the more relevant vesicle SNARE for this reaction. The 
control SNARE protein STX13 failed to inhibit transport when 
added to similar concentrations. Together, these experiments im-
plicate a SNARE complex comprised of STX10, STX16, Vti1a, 
and VAMP3 in the transport of MPRs from late endosomes to 
the Golgi complex. This set of SNAREs includes one member 
each from the categories Qa, Qb, Qc, and R SNAREs that are re-
quired to form a functional SNARE complex (  Jahn and Scheller, 
2006  ). Further evidence suggesting that these SNAREs function 
in a common step (and thus are members of the same complex) 
is shown in   Fig. 1 D  ; the inhibitory effects of STX10 and 16 
were not additive. This specific SNARE complex (STX10  –
 STX16 – Vti1a – VAMP3)  has  been  detected in living cells (  Wang 
et al., 2005  ), but its precise function was unknown until now. 
  To verify the physiological signifi  cance of our in vitro ex-
periments, we tested the consequences of soluble SNARE pro-
tein overexpression in cultured cells. A block in MPR recycling 
caused by an inhibitory SNARE protein should decrease the 
level of MPRs available within the Golgi to transport newly 
synthesized lysosomal hydrolases effi  ciently. Under these con-
ditions, hydrolases would be missorted and secreted. Thus, hexos-
  Figure 2.       Hexosaminidase secretion is increased in cells when STX10, 
STX16, or Vti1a function is compromised.   (A) HeLa cells grown in 6-cm 
dishes were either mock transfected (control) or transfected with the indi-
cated myc-tagged cytosolic SNARE and incubated in fresh media for 8 h
to collect secreted hexosaminidase. (B) Immunoblot of overexpressed 
SNARE proteins from the cells analyzed in A and a portion of the Ponceau S  – 
stained ﬁ  lter as a loading reference. Proteins were detected with anti-myc 
tag antibody. (C) Hexosaminidase secretion from control or STX10-depleted 
HeLa cells. The top panel shows a Ponceau S  –  stained immunoblot mem-
brane (top bar) of HeLa cell lysate reacted with antibodies to monitor 
STX10 depletion. Numbers at the right in B and C indicate   M    r   in kilodaltons. 
(A and C) Values are means from at least three independent experiments 
performed in triplicate; error bars represent SD.     JCB • VOLUME 180 • NUMBER 1 • 2008  162
shows that STX10 was the most potent inhibitor. VAMP4 was 
poorly expressed; therefore, the results for this SNARE are in-
conclusive. Only a slight increase in hexosaminidase secretion 
was seen in cells overexpressing VAMP3. Together, these data 
support the in vitro fi  ndings (  Fig. 1  ) and the conclusion that a 
STX10 – STX16 – Vti1a-containing  complex  is  needed for MPR 
recycling in living cells. In addition, soluble v-SNAREs were 
less potent inhibitors than soluble t-SNAREs both in vitro (  Fig. 1  ) 
and upon expression in cultured cells (  Fig. 2  ). 
 We  confi  rmed the importance of the STX10 t-SNARE in 
MPR traffi  cking by siRNA depletion (  Fig. 2 C  , inset). In cells 
depleted of     90% of their STX10 content, hexosaminidase 
  secretion was stimulated     2.5-fold (  Fig. 2 C  ). Thus, by two 
  independent criteria, STX10 is required for proper lysosomal 
enzyme sorting in living cells. 
  Loss of STX10 enhances MPR degradation 
  Steady-state levels of MPRs were also signifi  cantly decreased 
in cells depleted of STX10 and, to a lesser extent, in cells de-
pleted of STX16 (  Fig. 3 A  ) relative to a control protein, p115. 
This is reminiscent of the increased turnover of MPRs observed 
when cells are depleted of TIP47, Rab9, or GCC185 (  Diaz and 
Pfeffer, 1998  ;   Ganley et al., 2004  ;   Reddy et al., 2006  ) or seen 
upon the loss of Retromer and PIKfyve proteins (  Arighi et al., 
2004  ;   Seaman, 2004  ;   Rutherford et al., 2006  ). 
  Interestingly, siRNA depletion of STX16 led to a concomi-
tant 80% loss of STX6 with little change in STX10; the deple-
tion of STX6 led to a 30% loss of STX16. This suggests that the 
majority of STX6 is complexed to a signifi  cant fraction of STX16 
in the cell and that STX16 is an important stabilizer of STX6. 
Cells depleted of STX10 showed increased levels of STX6 (60%) 
and STX16 (40%;   Fig. 3, A and B  ). In contrast, the depletion of 
STX6 led to a 60% increase in STX10 levels. It is possible that 
the depletion of one SNARE frees up STX16 to provide addi-
tional stabilization for another partner SNARE protein. 
  The loss of MPRs in STX10-depleted cells was caused by 
an increase in their degradation rate as measured in a pulse-
chase labeling experiment. Cells were transfected with STX10 
siRNA at time zero, and the loss of STX10 protein was moni-
tored. At 45 h of siRNA treatment, STX10 protein was de-
creased by 36%; by 54 h, it was decreased by 83% (  Fig. 3 C  ). 
Cells were pulse labeled with [ 
35  S]methionine and cysteine, and 
the chase was begun at a time when STX10 began to be signifi  -
cantly depleted. MPR levels were then determined at various 
times by immunoprecipitation. As shown in   Fig. 3 D  , cells de-
pleted of STX10 showed signifi  cantly increased MPR degrada-
tion compared with control-treated cells. The half-life of MPRs 
was estimated to be     13 h in the absence of STX10, which was 
much shorter than that of control cells (  >  36 h) under these con-
ditions. This confi  rms the importance of STX10 for MPR stabil-
ity and, by inference, MPR traffi  cking. 
  Figure 3.       MPRs are destabilized in cells depleted of STX10.   CI-MPR 
and SNARE protein levels in HEK293 cells transfected with the indicated 
siRNAs. (A) Immunoblot. (B) Quantitation of the data shown in A. Values 
are from two independent experiments, normalized to p115 levels rel-
ative to protein levels in control transfected cells. Error bars represent SD. 
(C) Kinetics of STX10 depletion after siRNA transfection of HEK293 cells. 
The inset shows an immunoblot of STX10 monitored at the indicated times. 
Quantitation of those data is graphed; two independent experiments per-
formed in duplicate are presented. (D) Half-life of CI-MPRs in cells depleted of 
STX10 measured at the times indicated after siRNA transfection. Numbers at 
the right in A and C indicate   M    r   in kilodaltons.     
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independent (CI) MPRs ( Fig. 4 A , top; cell at bottom left). In con-
trast, cells depleted of STX10 (  Fig. 4 A  , arrows) showed highly 
dispersed staining for CI-MPRs (  Fig. 4 A  , top right; arrows). 
Under these conditions, the TGN was intact as determined by the 
  MPR missorting in cells lacking STX10 
  The missorting of MPRs in cells depleted of STX10 was con-
fi  rmed by light microscopy. As shown in  Fig. 4 A , cells containing 
STX10 showed a typical perinuclear concentration of cation-
  Figure 4.       Depletion of STX10 leads to CI-MPR dispersal to sorting nexin-2  –  positive structures but does not disrupt Golgin 97 localization.   (A) Summation 
of confocal z sections of HeLa cells treated with STX10 siRNA and double labeled with rabbit anti-STX10 and mouse anti  –  CI-MPR (top) or rabbit anti-STX10 
and mouse anti  –  Golgin 97 (bottom). Arrows point to cells depleted of STX10. Bar, 10   μ  m. (B) Quantitation of CI-MPR dispersal in cells depleted of STX10. 
Peripheral CI-MPR  –  positive vesicles were determined as described in Materials and methods. The mean number of vesicles from three separate cells normal-
ized for cell area is shown. Error bars represent SD. (C) Deconvolution microscope image showing colocalization of endogenous CI-MPR (stained red with 
mouse antibody) and sorting nexin-2 (stained green with rabbit antibody) in the periphery of a HeLa cell depleted of STX10. Bar, 5   μ  m. (D) Venn diagrams 
representing the quantitation of colocalization between sorting nexin-2 and EEA1 or sorting nexin-2 and CI-MPR in nonperinuclear regions of control and 
STX10-depleted HeLa cells. Vesicles were from nine (control) or seven (STX10 depleted) separate cells from two independent experiments. Venn diagrams 
are correctly scaled for percentage overlap to permit the direct comparison of antigens in each vesicle population.     JCB • VOLUME 180 • NUMBER 1 • 2008  164
sorting nexin-2 positive in STX10-depleted cells (  Fig. 4, C and D  ). 
A signifi  cant proportion of sorting nexin-2 protein colocalizes 
with early endosome markers such as early endosome antigen 1 
(EEA1;   Arighi et al., 2004  ;   Seaman, 2004  ;   Carlton et al., 2005  ; 
  Rojas et al., 2007  ). In the current study, EEA1 was present on 
44% (304/695) of sorting nexin-2  –  positive structures in control 
cells; only 123/942 (13%) of the peripheral sorting nexin-2 struc-
tures contained CI-MPRs, and few peripheral MPR structures 
were observed (159;   Fig. 4 D  ). Upon STX10 depletion, 43% 
(301/708) of sorting nexin-2  –  positive vesicles contained EEA1, 
and 84% (766/916) contained CI-MPRs. As before, we saw 
localization of the TGN protein Golgin-97 (  Fig. 4 A  , bottom). 
Therefore, in cells lacking STX10, CI-MPRs are mislocalized to 
vesicles that are dispersed throughout the cytoplasm. Quantita-
tion of the peripheral vesicles showed that their number increased 
more than twofold in cells depleted of STX10 (  Fig. 4 B  ). 
  Characterization of the accumulated vesicles revealed that 
they contain sorting nexin-1 (not depicted) and sorting nexin-2 
proteins (  Fig. 4 C  ), which are constituents of the retromer com-
plex that is important for MPR recycling to the trans-Golgi com-
plex (  Arighi et al., 2004  ;   Seaman, 2004  ;   Rojas et al., 2007  ). 
Indeed, 85% (766/904) of peripheral MPR-positive vesicles were 
  Figure 5.       Cholera toxin B fragment transport 
in cells depleted of STX10 or 6.   (A) HeLa cells 
were treated with control siRNA (left) or STX10 
siRNA (right) and were allowed to internalize 
AlexaFluor488-conjugated cholera toxin B 
(CTxB) for 30 min followed by a 30-min chase. 
Cholera toxin B or rabbit anti-STX10 staining 
(detected with AlexaFluor 94 anti  –  rabbit) is 
indicated at the left. (B) Control (left) and STX6-
depleted (right) HeLa cells were treated with 
cholera toxin B as in A. Cholera toxin B and 
mouse anti-STX6 staining (detected with Alexa-
Fluor594 anti  –  mouse) of the same cells is indi-
cated at the left. (C) Quantitation of the data 
shown in A and B. The numbers of cells counted 
(  n  ) were from three independent   experiments, 
and error bars represent SD. Bars, 10   μ  m.     165 STX10 AND GCC185 IN LATE ENDOSOME  –  TGN TRANSPORT   •   GANLEY ET AL.
a vesicular pattern for TGN46 in   >  80% of cells scored (  Fig. 6  , 
middle; arrows). This was not caused by disruption of the TGN, at 
least by the criteria of GCC185 staining (  Fig. 6  , bottom; arrows). 
  These data directly show that the transport of proteins 
from early and late endosomes to the Golgi complex are medi-
ated by distinct SNARE protein complexes: a SNARE complex 
containing STX6, STX16, and Vti1a mediates the receipt of 
cargo from early endosomes, whereas a complex containing 
STX10, STX16, and Vti1a mediates the receipt of cargo from 
late endosomes. Moreover, they reveal that the steady-state lo-
calization of TGN46 is sensitive to the loss of STX6, a fi  nding 
that suggests that this protein follows a transport route that is 
shared with cholera toxin but is distinct from MPRs. 
a signifi  cant increase in peripheral MPR-positive structures 
(904/159). These peripheral MPRs showed a similar degree of 
overlap with EEA1 as sorting nexin-2 in STX10-depleted cells 
(    45%; unpublished data). In summary, upon the loss of STX10, 
the newly peripheral MPRs are tightly associated with sorting 
nexin-2 in small peripheral structures; at least some of these 
  represent early endosomes because of their content of EEA1. 
  Are the peripheral MPR-containing structures that accu-
mulate in STX10-depleted cells transport vesicle intermediates? 
If so, they would be expected to contain Rab9, which resides on 
the surface of vesicles traversing from late endosomes to the 
trans-Golgi (  Barbero et al., 2002  ). HeLa cells depleted of the 
putative tether GCC185 also accumulate MPRs in peripheral 
vesicles, the majority of which contain Rab9 protein (  Reddy 
et al., 2006  ). In contrast, in STX10-depleted cells, only 18% 
(15/84) of MPR-containing, peripheral vesicles also contained 
Rab9 (unpublished data). This suggests that MPRs are blocked 
in a prelate endosome compartment before a Rab9-dependent 
vesicle transfer process.   Wang et al. (2005)   showed that cells 
depleted of STX10 display an alteration in transferrin receptor 
localization. If STX10 participates in more than one transport 
event, its depletion could lead to the accumulation of MPRs 
in a peripheral Rab9-negative prelate endosome compartment. 
Importantly, because our in vitro transport assay measures 
transport from a late endosome compartment (  Goda and Pfeffer, 
1988  ), we are able to discern a specifi  c role for STX10 in trans-
port from that compartment to the Golgi complex. 
  STX10 functions in the late endosome to 
Golgi pathway 
  To verify that STX10 is required at the TGN for the receipt of 
late endosome but not early endosome-derived cargoes, we tested 
whether cells depleted of this t-SNARE were competent to 
transport cholera toxin B from early endosomes to the Golgi com-
plex. For these experiments, fl  uorescent cholera toxin B fragment 
was internalized by receptor-mediated endocytosis for 30 min, 
and its arrival to the TGN was monitored microscopically after 
an additional 30 min. As shown in   Fig. 5 A  , the depletion of 
STX10 did not compromise the ability of HeLa cells to transport 
fl  uorescent cholera toxin B fragment from the early endocytic 
pathway to the TGN. In contrast, consistent with previous papers 
studying Shiga toxin (  Mallard et al., 2002  ;   Wang et al., 2005  ), 
the disruption of STX6 blocked this transport step (  Fig. 5 B  ). 
As was true for STX10 depletion, the loss of STX6 did not alter 
the TGN, as monitored by immunostaining for Golgin-97 (not 
depicted) or GCC185 (  Fig. 6  ), suggesting that cholera toxin 
mislocalization in STX6-depleted cells is not simply caused by 
Golgi complex disruption. Quantitation of these experiments 
revealed a block in cholera toxin transport in   >  50% of cells ana-
lyzed (  Fig. 5 C  ). This morphological determination provides a 
minimum estimate of the extent of a block in transport, as only 
severely impaired cells are scored. 
  As an independent test of the specifi  city of STX10, we also 
examined the localization of TGN46, a protein that shuttles 
  between endosomes and the Golgi complex (  Fig. 6  ). Cells de-
pleted of STX10 showed perfect Golgi localization of TGN46 
(  Fig. 6  , top; arrows). In contrast, cells depleted of STX6 showed 
  Figure 6.       TGN46 transport in cells depleted of STX10 or S6.   HeLa cells 
were treated with STX10 siRNA (top) or STX6 siRNA (middle) and were 
stained for the indicated proteins; TGN46 was detected with sheep anti-
body and AlexaFluor594 anti  –  sheep antibodies. Arrows point to SNARE-
depleted cells, and asterisks mark undepleted cells. The bottom panel presents 
quantitation of the data shown. The numbers of cells counted (  n  ) were from 
two independent experiments; error bars represent SD. Bar, 10   μ  m.     JCB • VOLUME 180 • NUMBER 1 • 2008  166
demonstrate that STX16 has the capacity to bind directly to 
GCC185. Although the binding is of low effi  ciency, it is specifi  c. 
  We next tested whether full-length cytosolic GCC185 
bound to immobilized SNARE proteins. In this case, GST-
tagged STXs were incubated with cytosol; bound proteins were 
collected on glutathione  –  Sepharose beads and analyzed by 
immunoblotting. As shown in  Fig. 7 B  (top), full-length GCC185 
bound to immobilized STX16 but did not show signifi  cant 
interaction with STX6, STX13, or the GST control (  Fig. 7 C  ). 
In contrast, the structurally related Golgin-97 failed to bind 
to any of these SNARE proteins (  Fig. 7 B  , middle). This was 
somewhat surprising, as Golgin-97 is implicated in early endo-
some to TGN transport (  Lu et al., 2004  ), and it might have shown 
binding to STX6 or 16, which participate in that transport step. 
In summary, these data confi  rm the ability of STX16 to bind 
specifi  cally to full-length GCC185. 
  A STX10 SNARE complex component 
binds the GCC185 tether 
  Essentially every putative tether studied to date interacts with 
cognate SNARE proteins (for review see   Lupashin and Sztul, 
2005  ). Thus, we were interested to test whether components of 
the STX10 complex interact with GCC185. GCC185 is a long 
coiled-coil protein that is required for MPR transport to the 
Golgi complex in vitro and in vivo (  Reddy et al., 2006  ). In addi-
tion, GCC185 binds directly to the Rab9 GTPase, which is also 
needed for this transport process (  Reddy et al., 2006  ). 
  We incubated purifi  ed, soluble SNARE proteins with recom-
binant GCC185 protein and analyzed bound proteins by immuno-
blotting. For these experiments, a GCC185 fragment comprised of 
the 110 C-terminal  –  most amino acids (C-110) was used. Impor-
tantly, the GCC185 C terminus bound directly to GST-STX16 
but not to GST-STX10, -STX13, or Vti1a (  Fig. 7 A  ). These data 
  Figure 7.       STX16 interacts directly and speciﬁ  cally with GCC185.   (A) GST-tagged cytosolic SNAREs were incubated with puriﬁ  ed GCC185  –  C-110. Tagged 
SNAREs were recovered by glutathione  –  Sepharose beads, and the bound proteins were analyzed by SDS-PAGE and immunoblotting with rabbit anti-
GCC185 (top) to detect bound C-110 or with rabbit anti-GST (bottom) to detect input SNAREs. Input lane at the left (top row) represents 2% of the total 
GCC185  –  C-110 used in each reaction. (B) STX16 interacts with full-length GCC185. Recombinant GST-tagged soluble SNARE proteins were incubated 
with K562 cell cytosol; the tagged SNAREs were then retrieved with glutathione  –  Sepharose beads. Bound proteins were analyzed by SDS-PAGE and 
immunoblotting to detect bound, full-length GCC185 (top), full-length Golgin97 (middle), or resin-bound GST-SNARE proteins (bottom). The input lane repre-
sents 1% of the total cytosol used in each reaction. (C) Quantitation of the data shown in B. Error bars represent SD from two independent experiments. 
(D) STX10, STX16, and Vti1a coimmunoprecipitate with GCC185. HeLa cells expressing the myc-tagged soluble SNAREs were lysed and incubated with equal 
amounts of either control serum or anti-GCC185 serum. Immune complexes were isolated with protein A  –  agarose, and bound proteins were analyzed by 
SDS-PAGE and immunoblotting with either rabbit anti-GCC185 serum (top) or mouse anti-myc antibody to detect exogenous SNARE proteins. A Ponceau S  – 
stained region of the gel is shown as a loading control for IgG at the bottom. Numbers next to the gels in A, B, and D indicate   M    r   in kilodaltons.     167 STX10 AND GCC185 IN LATE ENDOSOME  –  TGN TRANSPORT   •   GANLEY ET AL.
fails to bind Rab GTPases (  Schweizer Burguete et al., 2008  ) 
also failed to bind STX16 (  Fig. 8 B  ), which is consistent with 
these proteins sharing interaction sites on GCC185. Failure to 
bind was not the result of protein misfolding, as the mutant pro-
tein is entirely dimeric and soluble (unpublished data). 
  In summary, these data demonstrate a role for STX10  –
  STX16  –  Vti1a and VAMP3 in the transport of MPRs (but not 
TGN46 or cholera toxin) from late endosomes to the TGN. 
In addition, the putative tether for this transport reaction, GCC185, 
binds to the t-SNARE complex that mediates vesicle fusion. 
Finally, the ability of a Rab GTPase that would be present at the 
target membrane to regulate SNARE – tether interactions implies 
that Rabs may regulate such interactions during or after vesicle 
docking and fusion. 
  Discussion 
  We have shown here that the t-SNAREs STX10, STX16, and 
Vti1a and the v-SNARE VAMP3 participate in the recycling of 
MPRs from late endosomes to the Golgi complex. Antibodies 
specifi  c for several of these proteins interfered with transport 
of the CD-MPR in vitro. In addition, overexpression of most 
of these proteins in cultured cells triggered lysosomal enzyme 
missorting, as detected by hypersecretion of the lysosomal en-
zyme hexosaminidase. This assay monitors the functions of 
both CI- and CD-MPRs. CI-MPRs were also destabilized in 
STX10-depleted cells, further supporting a requirement for 
this t-SNARE in MPR traffi  cking in vivo. Moreover, as would 
be expected for an MPR-recycling t-SNARE, the depletion of 
STX10 from cells led to the dispersal of endogenous CI-MPRs 
to peripheral vesicles. These vesicles were decorated with the 
retromer subunits sorting nexin-1 and -2, which are also im-
portant for MPR recycling to the Golgi (  Arighi et al., 2004  ; 
  Seaman, 2004  ;   Rojas et al., 2007  ). These fi  ndings place the 
retromer complex upstream of both STX10 function and the 
GCC185 tethering complex in MPR transport. Together, our 
data suggest that STX10, STX16, Vti1a, and VAMP3 are im-
portant for the traffi  cking of both CD- and CI-MPRs. To our 
  STX16 could interact with GCC185 alone or as part of an 
intact SNARE complex. As shown in   Fig. 7 D  , incubation of 
cell extracts with anti-GCC185 antiserum led to the coimmuno-
precipitation of small amounts of coexpressed, myc-tagged, 
soluble STX10, STX16, and Vti1a but not STX13, VAMP3, or 
VAMP4. This protocol would yield an underestimate of protein 
interactions because the initial GCC185 immunoprecipitation 
was of low effi  ciency (  Fig. 7 D  , top). Together, these data sug-
gest that GST-STX10 and Vti1a can interact with GCC185 indi-
rectly as part of an STX16-containing complex of t-SNARE 
proteins (  Fig. 7 A  ). 
  If this conclusion is correct, STX16 might also mediate the 
interaction of GCC185 with the STX6  –  STX16  –  Vti1a complex. 
As shown at the bottom of   Fig. 7 D  , myc-tagged soluble STX6 
was also coimmunoprecipitated with GCC185 antibodies. 
Again, this interaction was indirect, as full-length GCC185 
failed to bind to immobilized STX6 protein (  Fig. 7 B  ). However, 
we found no evidence that GCC185 interacts functionally with 
this complex in vivo, as the depletion of GCC185 did not pre-
vent cholera toxin transport to the Golgi (Fig. S1 B). It should be 
noted that   Derby et al. (2007)   reported a requirement for 
GCC185 in Shiga toxin transport, but the Golgi complex was 
much more disrupted in those siRNA depletion experiments than 
seen in our studies, and Golgin-97 may have been codepleted 
upon the effi  cient loss of GCC185 (  Reddy et al., 2006  ). 
  The ability of STX16 to bind to the GCC185 C terminus 
led us to test whether Rab GTPase binding might compete for 
this interaction because we have shown that the GCC185 C ter-
minus also contains a Rab-binding site (  Reddy et al., 2006  ). The 
C-110 fragment binds to both Rab6 and Rab9 GTPases but not 
Rab1 or Rab5 GTPases (  Reddy et al., 2006  ;   Schweizer Burguete 
et al., 2008  ), and Rab binding might regulate SNARE inter-
action. As shown in   Fig. 8 A  , STX16 binding to GCC185 was 
decreased when reactions contained Rab6-GTP. At the same 
concentrations, Rab9 had less of an effect (unpublished data). 
Competition was specifi  c for the active Rab protein in that 
Rab6-GDP failed to compete with STX16 for GCC185 binding. 
A mutant GCC185 protein construct (I1588A/L1595A) that 
  Figure 8.       Rab6 competes with STX16 for 
GCC185 binding.   (A) Puriﬁ  ed,  GCC185  – 
C-110 and GST-soluble STX16 were incubated 
together, either alone or with Rab6 preloaded 
with GDP or GTP    S. GST-STX16 was recovered
with glutathione  –  Sepharose beads; the bound 
GCC185  –  C-110 was analyzed by SDS-PAGE, 
and the immunoblot was probed with anti-
GCC185 antibody. Immunoblots were quanti-
ﬁ  ed; the amount of GCC185  –  C-110 binding 
to STX16 relative to binding in the absence of
Rab protein (control) from two independent 
experiments is shown. Error bars represent SD. 
(B) Equal amounts of puriﬁ  ed GCC185  –  C-110 
wild type or GCC185  –  C-110 IL/AA were 
incubated with GST-tagged soluble STX16. 
GST-STX16 was recovered with glutathione  –
  Sepharose beads, and the bound proteins were 
analyzed by SDS-PAGE and immunoblotting 
with rabbit anti-GCC185 (top) to detect C-110
or with rabbit anti-GST (bottom) to detect STX16. 
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tether, and STX10 all interfere with MPR traffi  cking in vitro and 
in vivo. Upon the depletion of components thought to mediate 
transport vesicle formation (Rab9 and TIP47), MPRs are de-
stabilized and subject to premature degradation as a result of mis-
sorting to the lysosome. Loss of components believed to be 
important for vesicle docking and fusion leads to the accumula-
tion of MPRs in small peripheral vesicles. In the case of GCC185, 
these vesicles carry Rab9 and do not represent early endosomes 
because they do not contain Rab5 or EEA1 ( Aivazian et al., 2006 ; 
  Reddy et al., 2006  ). Thus, these vesicles may represent transport 
intermediates. In STX10-depleted cells, the peripheral vesicles 
are distinct from those that accumulate in the absence of GCC185 
and are likely to represent a block at a prelate endosome stage 
because they do not contain Rab9 GTPase. STX10 binds STX13 
(  Wang et al., 2005  ), which does not participate in late endosome 
to TGN transport but has been implicated in transferrin receptor 
recycling (  Prekeris et al., 1998  ). Also, multiple roles for a 
t-SNARE are not uncommon: for example, STX6 is needed for 
homotypic fusion of early endosomes and immature secretory 
granules, exocytosis in neutrophils (  Wendler and Tooze, 2001  ), 
and early endosome to TGN transport of Shiga toxin (  Mallard 
et al., 2002  ). Our ability to monitor transport from late endo-
somes to the TGN in vitro enables us to be precise in specifying 
one of STX10  ’  s functional assignments. 
  The route of MPR recycling to the TGN 
  Understanding the routes by which MPRs return to the Golgi 
complex has been somewhat confused by the observation that 
depletion of the clathrin adaptor AP-1 (  Meyer et al., 2000  ) and 
the retromer coat complex (  Arighi et al., 2004  ;   Seaman, 2004  ) 
leads to the morphological accumulation of MPRs in early 
  endosomes. Because MPRs were seen to accumulate in early 
endosomes in AP-1  –  depleted cells and because retromer subunits 
themselves localize to early endocytic compartments, some have 
concluded that transport to the Golgi might occur directly from 
early endosomes. 
  There is no question that AP1 and retromer are essential 
for MPR transport. However, the additional requirement for the 
late endosomal Rab9 GTPase (  Lombardi et al., 1993  ;   Riederer 
et al., 1994  ;   Iversen et al., 2001  ;   Ganley et al., 2004  ) must be 
incorporated into any model for MPR recycling. Expression of 
endogenous levels of a dominant-negative Rab9 mutant triggers 
the missorting of lysosomal enzymes, inhibits the return of 
CI-MPRs to the TGN (as monitored directly by their failure to 
be resialylated), increases the cell surface pool of MPRs, and 
induces the compensatory expression of MPRs and other lyso-
somal enzymes (  Riederer et al., 1994  ). Loss of Rab9 by siRNA 
has similar phenotypic consequences (  Ganley et al., 2004  ), and 
the addition of Rab9 stabilizes MPRs in cells in which Rab9 
function is compromised (  Ganley and Pfeffer, 2006  ). The same 
is true in cells lacking the Rab9 effectors TIP47 ( Diaz and Pfeffer, 
1998  ;   Ganley et al., 2004  ) and GCC185 (  Reddy et al., 2006  ): 
the loss of either of these effectors strongly destabilizes MPRs. 
Thus, although a direct path from early endosomes to the Golgi 
might be viewed as the simplest model, many lines of evidence 
show that cells use the late endosomal Rab9 and its effectors for 
biochemically scored MPR return to the Golgi. 
knowledge, this is the fi  rst study to assign a role to STX10 
in a specifi  c transport step, that of fusion of MPR-containing 
vesicles at the TGN. In addition, we present evidence that is 
consistent with a possible additional role for STX10 in the 
fusion of retromer-positive structures with a later endosomal 
compartment. However, it is important to note that the STX10 
gene is absent from rats and mice, which implies that another 
mechanism must replace STX10 function in these organisms. 
There are numerous examples of molecular differences in 
fundamental processes between humans and mice and rats. 
Receptors used by natural killer cells are of entirely differ-
ent structural classes (  Parham, 2005  ). The G protein  –  coupled 
thrombin receptors in humans and mice are distinct and acti-
vated by rather different mechanisms (  Coughlin, 2005  ). In mem-
brane traffi  c, most vertebrates except rats and mice express 
the CHC22 clathrin isoform that is encoded on human chromo-
some 22 (  Wakeham et al., 2005  ). The precise role of CHC22 
will be interesting and important to determine even if it is not 
present in rats and mice. 
  A search of the Ensembl genome database (  Hubbard et al., 
2007  ) reveals that in addition to humans, 11 diverse organisms 
contain an STX10 homologue in addition to STX6. These 
include chimpanzees, cows, dogs, a rodent (  Spermophilus tride-
cemlineatus  ), fugu fi  sh, and frogs, and the list is likely to in-
crease when more genomes become available. Expression data 
from expressed sequence tag, sage, and microarray experiments 
(  Skrabanek and Campagne, 2001  ;   Huminiecki et al., 2003  ) 
show that STX10 has a ubiquitous expression profi  le that is es-
sentially identical to that of STX6. However, STX10 and 6 are 
only 61% identical (75% similar) in sequence, and our data 
show that the proteins have very distinct functions in vitro and 
in vivo. Future experiments will reveal the solution used by rats 
and mice to transport MPRs to the Golgi. 
 A recent study by  Wang et al. (2005)  suggested that STX10 
may not be essential for MPR recycling. However, these conclu-
sions were based on a modest morphological change in MPR 
localization. In this study, different STX10 siRNA target sequences 
were used, resulting in a more effi  cient depletion of STX10 and 
a signifi  cant change in MPR localization. In addition, in vitro 
biochemical approaches as well as in vivo lysosomal hydrolase 
sorting assays (in response to protein depletion or overexpres-
sion) confi  rm a role for STX10 in MPR recycling. 
  Recent work has suggested that an STX5-containing 
SNARE complex may also be involved in endosome to Golgi 
recycling of MPRs (  Amessou et al., 2007  ). However, siRNA 
depletion of STX5 led to a loss in Golgi integrity, making it dif-
fi  cult to rule out nonspecifi  c effects caused by disruption of the 
target membrane. In addition, that study used a chimera of GFP 
tagged to the transmembrane and cytosolic domains of CI-MPR, 
and this type of construct has been shown to traffi  c differently 
than wild-type MPRs (  Waguri et al., 2006  ). The experiments 
presented here show a clear, unambiguous role for the STX10-
containing SNARE complex in MPR recycling by several in-
dependent criteria. Importantly, soluble STX5 t-SNARE was 
without effect in our in vitro transport assay (  Fig. 1  ). 
  To date, we have demonstrated that depletion of Rab9 
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than one SNARE complex, but GCC185 seems to be most im-
portant for the STX10-dependent receipt of cargoes arriving at 
the Golgi from late endosomes. It is important to acknowledge 
that our SNARE binding studies analyzed the association of 
soluble, nonnative SNARE proteins with their endogenous part-
ners. Although the binding was highly specifi  c, it is not clear 
that the soluble SNARE proteins will engage only catalytically 
competent SNARE complexes. We still do not fully understand 
how SNAREs themselves are localized and how functional, tri-
meric t-SNARE complexes relate in equilibrium with other 
SNARE complex subassemblies within biological membranes. 
Further analysis of the STX10- and STX6-containing SNARE 
complexes will resolve some of these questions. We are most 
excited about the prospect that tethers such as GCC185 may 
contribute to SNARE complex assembly, which was shown 
most elegantly for p115 in Golgi  –  SNARE complex assembly 
(  Shorter et al., 2002  ). 
  Rab6 is localized to the Golgi complex and may partici-
pate in recruiting cytosolic GCC185 to that compartment. We have 
shown here that Rab6 can compete with STX16 for inter-
action with GCC185 and that binding involves common amino 
acid residues near GCC185  ’  s C terminus. This suggests that 
Rab6 can regulate the binding of STX16 to GCC185. If tethers 
interact with SNARE proteins to catalyze SNARE complex as-
sembly, it is also important for tethers to be removed from such 
complexes so that they can drive membrane fusion. An appeal-
ing possibility is that Rab6 modulates a tether-mediated SNARE 
assembly reaction. Alternatively, Rab GTPases template the for-
mation of functional membrane microdomains (  Pfeffer, 2001  ; 
  Zerial and McBride, 2001  ). Perhaps Rab  –  tether and tether  –
  SNARE interactions recruit these proteins to a given membrane 
microdomain and, thereby, facilitate their ability to function. 
The functional consequences of Rab  –  tether and tether  –  SNARE 
interactions will be important areas for future investigation. 
  Materials and methods 
  Expression plasmids, recombinant proteins, and antibodies 
  SNARE protein DNA sequences lacking a transmembrane domain were 
ampliﬁ   ed from full-length cDNA clones obtained from American Type 
  Culture Collection or Deutsches Ressourcenzentrum f  ü  r Genomforschung 
(RZPD) and veriﬁ  ed by sequencing. DNA sequences were cloned into the 
 At steady state, MPRs are localized predominantly in peri-
nuclear late endosomes, as determined by quantitative electron 
microscopy in conjunction with specifi  c antibody labeling 
procedures (  Griffi  ths et al., 1988  ). Without double labeling for 
Golgi markers, perinuclear, late endosomal MPRs cannot be 
distinguished from the closely apposed (and even intertwined) 
Golgi complex (  Barbero et al., 2002  ). Live cell video micros-
copy has shown that MPRs fi  rst leave the Golgi in tubulo-
vesicular carriers and are delivered to early endosomes (  Waguri 
et al., 2003  ); the receptors then return to the perinuclear re-
gion, and, at steady state, most arrive in late endosomes. Live 
cell video microscopy has also detected the direct transfer of 
vesicles from Rab9-positive late endosomes to distinctly la-
beled Golgi complexes marked with GFP-galactosyltransferase 
(  Barbero et al., 2002  ). Transport of the native MPR from late 
endosomes to the Golgi is a relatively slow process (  Duncan 
and Kornfeld, 1988  ) that is not always accurately recapitulated 
by GFP-tagged MPR proteins (  Waguri et al., 2006  ). MPRs 
shift from late endosomes to early endosomes when cells are 
depleted of AP1 or retromer (  Arighi et al., 2004  ;   Seaman, 
2004  ). The simplest way to incorporate all of the published 
data are to propose that AP1 and retromer proteins function 
before MPRs arrive in late endosomes. Alternatively, some 
MPRs may traverse back directly from early endosomes, but 
Rab9, its effectors, and, in human cells, STX10 must still 
somehow participate. 
  Importantly, the molecular distinction between STX10- 
and Rab9-independent early endosome to Golgi transport of 
TGN46 and Shiga and cholera toxin versus the STX10/Rab9-
dependent transport of MPRs documented here provides mo-
lecular proof of the distinction between these two transport 
routes ( Fig. 9 ). The t-SNARE that receives cargo from early endo-
somes, STX6, is dispensible for MPR recycling in these cells. 
In summary, there is no question that retromer is important for 
MPR export from early endosomes, together with Shiga toxin 
export from the same compartment (  Bujny et al., 2007  ;   Popoff 
et al., 2007  ). However, these cargoes clearly diverge after a 
retromer-dependent step, as seen by their subsequent differential 
requirements for STX10 shown here. 
 Our  fi  nding that GCC185 can bind to STX16 raises sev-
eral interesting questions. The STX16 t-SNARE is part of more 
  Figure 9.       Summary diagram showing the distinct molecu-
lar requirements for transport from late endosomes and early 
endosomes to the TGN.   See Discussion for details. A role for STX6 
in cholera toxin transport is shown here. A role for STX6, Vti1a, 
and STX16 in Shiga toxin transport was shown by   Mallard et al.   
(  2002  ), and a role for STX16 was shown by   Wang et al. (2005  ). 
STX16 has also been shown to participate in cholera toxin re-
cycling (  Amessou et al., 2007  ). Therefore, we assume that cholera 
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siRNA directed against GFP was used as a negative control (  Chi et al., 2003  ). 
Speciﬁ  c silencing of targeted genes was conﬁ  rmed in at least three inde-
pendent experiments. 
  Assays 
  In vitro transport assays were performed as described previously (  Reddy 
et al., 2006  ). Puriﬁ  ed GST or GST-SNAREs were added at 100   μ  g/ml (unless 
otherwise stated) before 90 min of in vitro transport at 37  °  C. Pulse-chase 
turnover experiments were performed as described previously (  Ganley 
et al., 2004  ); radioactive precursor was added 38.5 h after siRNA transfec-
tion. Labeling was performed for 1.5 h. Samples were analyzed for MPR 
degradation beginning 48 h after siRNA addition when STX10 depletion 
was signiﬁ  cant. 
  Hexosaminidase secretion 
  Assays were performed as described previously (  Riederer et al., 1994  ). 
HeLa cells were transfected with myc-tagged cytosolic SNARE constructs 
for 24 h or with STX10/control siRNAs for 72 h. Cells were incubated in 
phenol red  –  free DME supplemented with 10 mM mannose 6-phosphate 
(Sigma-Aldrich) for 8 h before assay. Myc-tagged cytosolic STX6, Vti1a, 
VAMP3, and VAMP4 contained LEHASRGPYSIVSPKC C terminal to the 
cytosolic domain. 
  Immunoﬂ  uorescence microscopy and immunoblots 
  Cell ﬁ  xation, staining, and mounting in mowiol were described previously 
(  Ganley et al., 2004  ). Goat anti  –  rabbit AlexaFluor488 and goat anti  –
  mouse AlexaFluor594 were used. Micrographs in   Figs. 4 A, 5 (A and B), 
6,   and S1 were acquired using a microscope (Axioplan2; Carl Zeiss, Inc.) 
ﬁ  tted with a 63  ×  /NA 1.30 plan Neoﬂ  uar objective lens and a CCD cam-
era (AxioCamHRc; Carl Zeiss, Inc.) and controlled by Axiovision 4.6 soft-
ware (Carl Zeiss, Inc.). Pictures were analyzed using Photoshop (Adobe). 
  Fig. 4 (C and D)   was obtained with a deconvolution microscopy system 
(Spectris; Applied Precision) with an inverted epiﬂ  uorescence microscope 
(IX70; Olympus), a plan Apo 60  ×  /1.40 NA oil immersion objective 
(Olympus), a CCD camera (CoolSNAP HQ; Roper Scientiﬁ  c), and Delta-
Vision acquisition and deconvolution software (Applied Precision). Some 
images quantiﬁ  ed in 4D were also acquired using a spectral confocal micro-
scope system (DM6000B; Leica) using a 63  ×  /NA 1.40 lens and confocal 
software (Leica). The perinuclear region (mean area of 54   μ  m 
2  ) was excluded 
from the analysis to ensure characterization of nonlate endosome structures. 
Immunoblot analysis and quantiﬁ  cation of proteins were previously described 
(  Ganley et al., 2004  ). 
  Cholera toxin uptake 
  HeLa cells transfected with the indicated siRNAs for 72 h were grown on 
glass coverslips and incubated in media containing 4   μ  g/ml cholera toxin 
B subunit conjugated to AlexaFluor488 (Invitrogen) for 30 min at 37  °  C fol-
lowed by washing and a chase of 30 min at 37  °  C in toxin-free media. 
Cells were then ﬁ  xed and stained for immunoﬂ  uorescence. 
  Binding assays 
  1   μ  M of puriﬁ  ed GST  –  cytosolic SNARE proteins was incubated with 2   μ  M 
GCC185 C-110 in a volume of 300   μ  l of binding buffer (20 mM Hepes, 
pH 7.6, 250 mM KCl, 5 mM MgCl  2  , 0.2% Triton X-100, 0.1 mg/ml BSA, 
and 0.2 mM DTT) for 1 h with rotation at room temperature. GST-SNAREs 
were recovered using glutathione  –  Sepharose beads and washed three 
times in binding buffer. The amount of GCC185 C-110 associating with 
the GST-SNARE was determined by SDS-PAGE and immunoblotting. For 
binding assays involving His-Rab6, the Rab was ﬁ  rst preloaded with nucleo-
tide for 2 h at room temperature by incubating in 20 mM Hepes, pH 7.6, 
150 mM KCl, 2 mM EDTA, 1 mM MgCl  2  , 0.1 mg/ml BSA, 0.1 mM DTT, 
and 1 mM GDP or 1 mM GTP    S (Sigma-Aldrich). The concentration of 
Rab6 in the binding assay was 0.7   μ  M. 
  Cytosolic GCC185 binding to GST-SNAREs 
  0.4 nmol GST  –  cytosolic SNARE was incubated with 700   μ  g K562 cytosol 
(  Itin et al., 1997  ) in 0.5 ml of binding buffer for 1 h at room temperature 
with rotation. GST-SNAREs were isolated with glutathione  –  Sepharose 
beads and washed in binding buffer, and the associated proteins were 
analyzed by SDS-PAGE and immunoblotting. 
  Coimmunoprecipitation 
  HEK293 cells grown in 10-cm plates were transfected with the indicated 
myc-tagged cytosolic SNARE constructs. After transfection (24 h), cells were 
placed on ice, washed three times in ice-cold PBS, and lysed in 1 ml of 
GST fusion vector pGEX4T-1 (GE Healthcare) or pGEX6P-1 for Vti1b and 
transformed in   Escherichia coli   BL21(DE3) cells. Cytosolic, soluble domains 
of STX6 (mammalian gene collection 12919; residues 1  –  230; American 
Type Culture Collection), STX12 (IRATp970G0973D; residues 1  –  245; 
RZPD), VAMP3 (mammalian gene collection 14563; residues 1  –  75; Amer-
ican Type Culture Collection), VAMP4 (residues 1  –  110; a gift from R.H. 
Scheller, Genentech, South San Fransisco, CA), VAMP7 (IRATp970D0710D; 
residues 1  –  182; RZPD), and VAMP8 (mammalian gene collection 1585; 
residues 1  –  70; American Type Culture Collection) were induced with 0.5 
mM IPTG for 2 h at 37  °  C. STX11 (IRATp970B0847D; residues 1  –  277; 
RZPD), STX16 (mammalian gene collection 90328; residues 1  –  296; Amer-
ican Type Culture Collection), Vti1a (mammalian gene collection 9292; 
residues 1  –  192; American Type Culture Collection), and Vti1b (mamma-
lian gene collection 3767; residues 1  –  202; American Type Culture Collec-
tion) were induced with 0.5 mM IPTG for 4 h at 30  °  C. STX10 (mammalian 
gene collection 19625; residues 1  –  222; American Type Culture Collection 
was induced with 0.5 mM IPTG at room temperature for 6 h. Cells were 
  resuspended to 40 ml in cytosol buffer (25 mM Hepes, pH 7.4, 50 mM KCl, 
1 mM MgCl  2  , and 0.5 mM EDTA) containing 1 mM PMSF, 1 mM DTT, and 
DNase I. Cells were lysed using a French press, and lysates were centrifuged 
at 20,000 rpm for 30 min in a JA 20 rotor (Beckman Coulter). GST-SNAREs 
were puriﬁ  ed from clariﬁ  ed lysates using glutathione 4B  –  Sepharose beads 
(GE Healthcare) and eluted with cytosol buffer containing 20 mM glutathi-
one, pH 7.4, which was then removed by dialysis. 
  GST-STX10 was also puriﬁ  ed and refolded from inclusion bodies. Bac-
terial pellets were resuspended in 50 mM Tris, pH 8.0, 25% sucrose 
(wt/vol), 10 mM DTT, and 1 mM PMSF, lysed by French press, and clariﬁ  ed by 
a 30-min spin at 20,000 rpm in a JA-20 rotor. Pellets were resuspended three 
times and centrifuged at 10,000 rpm for 10 min in isolation buffer (20 mM 
Tris, pH 8.0, 2 M urea, 0.5 M NaCl, and 2% Triton X-100) and dissolved in 
solubilization buffer (20 mM Tris, 6 M guanidine HCl, 0.5 mM NaCl, 4 mM 
DTT, and 1 mM 2-mercaptoethanol, pH 8.0) for 1 h at room temperature with 
gentle agitation. Samples were ﬂ  ash frozen and stored at     80  °  C. For refold-
ing, 2 ml of solubilized inclusion bodies was added dropwise from a 25-
gauge needle to 200 ml of refolding buffer (100 mM Tris, pH 8.0, 400 mM 
  L  -arginine, 2 mM EDTA, 5 mM of reduced glutathione, 0.5 mM oxidized 
  glutathione, and 1 mM PMSF) at 4  °  C with constant stirring. After 15 h and an 
additional 8 h, another 2 ml of inclusion bodies was added. 15 h after the last 
addition, the sample was centrifuged at 40,000 rpm in a 45 Ti rotor (Beckman 
Coulter). The supernatant was concentrated and desalted into cytosol buffer 
using PD-10 columns (GE Healthcare). Correctly folded protein was isolated 
using glutathione 4B  –  Sepharose beads as before. 
  The GST-tagged C-terminal 110  –  amino acid fragment of GCC185 
(C-110) was puriﬁ  ed as described previously (  Reddy et al., 2006  ). For bind-
ing assays, the GST tag of C-110 was removed during puriﬁ  cation using 
20 U/ml thrombin (Sigma-Aldrich) for 2 h at room temperature. Thrombin was 
neutralized by the addition of 10 mM benzamidine (Sigma-Aldrich) followed 
by dialysis into 50 mM Hepes, pH 7.6, and 250 mM KCl. His-tagged (6  ×  ) 
human Rab6A in pET15b (a gift from T. Meyer, Stanford, Stanford, CA) was 
transformed into   E. coli   BL21(DE3) cells for protein expression. Cells (0.8 
OD  600  ) were induced for 16 h at room temperature with 0.5 mM IPTG. Cells 
were resuspended to 40 ml in lysis buffer (50 mM Tris, pH 8.0, 200 mM 
NaCl, 10 mM imidazole, 5 mM MgCl  2  , 0.2 mM DTT, and 10   μ  M GDP) con-
taining 1 mM PMSF. Cells were lysed using a French press, and lysates were 
centrifuged at 20,000 rpm for 30 min in a JA 20 rotor. His-Rab6A was puri-
ﬁ  ed using Ni-NTA agarose (QIAGEN) and eluted with lysis buffer containing 
200 mM imidazole followed by dialysis in 50 mM Tris, pH 8.0, 150 mM 
KCl, 5 mM MgCl  2  , 1 mM EDTA, and 10   μ  M GDP. Polyclonal antibodies 
against STX6, 10, 16, and Vti1a were gifts from J.E. Rothman (Columbia 
University, New York, NY). Monoclonal antibodies against STX6 were gifts 
from R.H. Scheller. Mouse anti  –  Golgin 97 was purchased from Invitrogen, 
sheep anti-TGN46 was obtained from Serotec, and rabbit anti-STX6 (C-19), 
which was used for immunoﬂ  uorescence, was purchased from Santa Cruz 
Biotechnology, Inc. Rabbit anti  –  sorting nexin-2 antibodies were gifts from 
C.R. Haft (National Institutes of Health, Bethesda, MD). Mouse anti-myc, rab-
bit anti-GST, and rabbit anti-GCC185 have been described previously 
(  Reddy et al., 2006  ). 
  Cell culture 
  HeLa and HEK293 cells were cultured and transfected as described previ-
ously (  Ganley and Pfeffer, 2006  ). RNAi was performed using siRNAs from 
Dharmacon. STX10 mRNA was targeted with the sequences GGAAGAGA-
CCATCGGTATA or TATCCCACATGACGAGTGA, and both siRNAs showed 
identical phenotypes. GACATCTTTGATCACCAGA was used to target STX6. 
siRNA directed against STX16 was described previously (  Wang et al., 2005  ). 171 STX10 AND GCC185 IN LATE ENDOSOME  –  TGN TRANSPORT   •   GANLEY ET AL.
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